Antiviral Drugs Market Size to Grow by $ 19.89 bn During 2021-2025

Technavio has been monitoring the antiviral drugs market and it is expected to grow by $ 19.89 bn, accelerating at a CAGR of almost 4% during the forecast period. The growth trajectory of the market is traced through a detailed analysis of the prevalent market forces, trends, and drivers along with competitive benchmarking.

Antiviral Drugs Market: Receive Free Sample Report

Antiviral Drugs Market: North America to lead market growth during the forecast period

• 44% of the market growth will originate from North America during the forecast period.
• Technological advancements will be a key trend that will influence market growth significantly.
• The growing cases of viral infections and anti-inflammatory therapeutics will be a significant factor in driving the growth of the antiviral drugs market.

Antiviral Drugs Market: Key Competitors

The market is fragmented. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. AbbVie Inc., Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., and Sanofi are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments.

For more insights on this market: Download a Free Sample Report

Antiviral Drugs Market: Key Highlights of the Report for 2021-2025

• CAGR of the market during the forecast period 2021-2025
• Detailed information on factors that will drive antiviral drugs market growth during the next five years
• Precise estimation of the antiviral drugs market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the antiviral drugs market industry across North America, Europe, Asia, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of antiviral drugs market vendors